ACTL6A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.718600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.189800E-01
Normal-vs-Stage2
5.848600E-01
Normal-vs-Stage3
4.548600E-01
Normal-vs-Stage4
3.639000E-01
Stage1-vs-Stage2
5.081800E-01
Stage1-vs-Stage3
3.167600E-01
Stage1-vs-Stage4
2.357800E-01
Stage2-vs-Stage3
1.192830E-01
Stage2-vs-Stage4
2.590200E-01
Stage3-vs-Stage4
1.644430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.916600E-01
Normal-vs-AfricanAmerican
6.913800E-01
Normal-vs-Asian
7.468800E-01
Caucasian-vs-AfricanAmerican
9.585400E-01
Caucasian-vs-Asian
9.430000E-01
AfricanAmerican-vs-Asian
9.332800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.082200E-01
Normal-vs-Female
6.261400E-01
Male-vs-Female
7.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.807600E-01
Normal-vs-Age(41-60Yrs)
4.474200E-01
Normal-vs-Age(61-80Yrs)
7.878800E-01
Normal-vs-Age(81-100Yrs)
6.229800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.439560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.357200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.126000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.433900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.477600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.962200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.628600E-01
Normal-vs-Daily Drinker
9.403200E-01
Normal-vs-Weekly Drinker
9.952000E-01
Normal-vs-Occasional Drinker
3.493200E-01
Normal-vs-Social Drinker
5.412000E-01
Non Drinker-vs-Daily Drinker
4.265800E-01
Non Drinker-vs-Weekly Drinker
5.598200E-01
Non Drinker-vs-Occasional Drinker
1.305010E-01
Non Drinker-vs-Social Drinker
5.592000E-01
Daily Drinker-vs-Weekly Drinker
8.799000E-01
Daily Drinker-vs-Occasional Drinker
4.029600E-02
Daily Drinker-vs-Social Drinker
2.145600E-01
Weekly Drinker-vs-Occasional Drinker
7.251900E-02
Weekly Drinker-vs-Social Drinker
2.709800E-01
Occasional Drinker-vs-Social Drinker
4.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.046000E-01
Normal-vs-Grade 2
4.788000E-02
Normal-vs-Grade 3
8.683900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.418900E-04
Grade 1-vs-Grade 3
3.811700E-04
Grade 1-vs-Grade 4
4.046000E-01
Grade 2-vs-Grade 3
1.684410E-01
Grade 2-vs-Grade 4
4.788000E-02
Grade 3-vs-Grade 4
8.683900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.765200E-01
Normal-vs-NonDiabetic
6.196600E-01
Diabetic-vs-NonDiabetic
1.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.653600E-01
Normal-vs-NoPancreatitis
6.961400E-01
Pancreatitis-vs-NoPancreatitis
9.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.770000E-01
Normal-vs-N1
5.927200E-01
N0-vs-N1
3.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.237190E-01
Normal-vs-TP53-NonMutant
9.446800E-01
TP53-Mutant-vs-TP53-NonMutant
5.96639999628223E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
